AKAlexander N. Konovalov

Alexander N. Konovalov

*This is an algorithmically generated author record based on publicly available information.

Alexander N. Konovalov has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Radiosurgery for neurosurgical diseases (by the 20th anniversary of neuroradiosurgery in Russia)

    by A.V. Golanov, D.Yu. Usachev, A.N. Konovalov

    Background. Ionizing radiation and radiotherapy/radiosurgery are widely used in modern medicine. Stereotactic approach and new irradiation techniques have enabled radiosurgical treatment with high precision and conformity. This significantly expanded the indications for radiotherapy in neurosurgical patients. Objective. To present more than 42 000 patients were treated at the first Russian center for stereotactic radiotherapy and radiosurgery at the Burdenko Neurosurgical Center over the past 20 years. Material and methods. Over 20 years, we have used linear accelerators and GammaKnife system for various CNS diseases. Results and conclusion. Stereotactic radiotherapy and radiosurgery have been shown to be highly effective treatments with minimal complications and adverse reactions for meningiomas, neurinomas, glomus tumors, hemangioblastomas, pituitary adenomas, craniopharyngiomas, pilocytic astrocytomas, recurrent high-grade gliomas, secondary metastatic tumors and melanoma; AVM and dural fistula; trigeminal neuralgia, and other diseases with high socioeconomic impacts. These results indicate the role of stereotactic irradiation in the treatment of neurosurgical patients today and allow for revision of existing neurosurgical treatment standards.


  • Transcranial motor evoked potentials in resection of supratentorial brain tumors adjacent to corticospinal tract in children

    by R.A. Kakhkharov, A.A. Ogurtsova, Sh.U. Kadyrov, K.N. Lapteva, A.A. Chitadze, A.N. Konovalov

    Background. Transcranial motor evoked potentials (TMEPs) are one of the methods allowing functional preservation of motor pathways in resection of tumors adjacent to corticospinal tract. Studies of this method in pediatric neurosurgery note some difficulties in data interpretation, but most demonstrate high efficacy even in younger children. Objective. To determine the role of TMEPs in surgical treatment of children with supratentorial tumors adjacent to corticospinal tract. Material and methods. There were 82 patients with intracerebral tumors who underwent 95 surgeries between January 2016 and December 2023. Age ranged from 6 months to 18 years. The study included patients with tumors of various hemispheric localizations, including deep neoplasms (57 patients). TMEPs were used in all patients. Results. Topography and histology of gliomas have no effect on stability of TMEPs at the beginning of surgery. Preoperative motor impairments significantly affect the amplitude and reproducibility of TMEPs. Age did not affect the amplitude of potentials, but reduced reproducibility was more common in children younger 5 years. Conclusion. Preoperative motor impairments are the leading cause of TMEP instability. Intraoperative dynamics of TMEPs predicts long-term functional outcomes. Partial or complete intraoperative reduction of TMEPs is a prognostically unfavorable factor for motor function recovery.

  • Pituitary adenoma combined with craniopharyngioma. Case reports and literature review

    by A.N. Konovalov, I.V. Chernov, M.V. Ryzhova, O.I. Sharipov, D.SH. Adueva, D.A. Konyashin, P.L. Kalinin

    Background. Combination of different intracranial tumors is an infrequent phenomenon. Combination of pituitary adenomas with craniopharyngiomas is extremely rare. Objective. To present exceptionally rare combinations of pituitary adenomas and craniopharyngiomas. Results. We present two patients with combinations of pituitary adenomas and adamantinomatous craniopharyngiomas. Due to topographic and anatomical features of neoplasms, combined access was used for resection of both tumors in the first case (transcallosal and transnasal in different surgeries). The second patient required simultaneous endoscopic transnasal resection of both tumors. Baseline symptoms (decreased vision in both cases and mental disorders in the first case) partially regressed, and patients were discharged.


  • Surgery for enlarged perivascular spaces: primary experience

    by A.A. Veselkov, A.V. Gavryushin, S.A. Maryashev, D.I. Pitskhelauri, T.L. Bekhtereva, A.N. Konovalov

    Perivascular spaces are cavities surrounding cerebral and spinal cord vessels and filled with cerebrospinal or intercellular fluid. Abnormal enlargement of these spaces can lead to neurological symptoms. Currently, there are no clear approaches to surgical treatment of this pathology. We set ourselves the task of analyzing the literature data, as well as presenting own clinical observations and sharing the experience of microsurgical treatment of this pathology. Material and methods. We reviewed the PubMed databases between 2009 and 2024. We analyzed own small sample (n=5) of patients with dilated perivascular spaces who underwent microsurgical treatment between 2009 and 2024. Four patients underwent microsurgical cystoventriculostomy, one patient — microsurgical cystocysternostomy and biopsy. Results. Microsurgical cystoventriculostomy and cyst drainage were less effective than expected. Four out of five patients developed new neurological symptoms after surgery, while baseline symptoms did not significantly regress. Conclusion. To date, cerebrospinal fluid shunting is still the main surgical method for dilated perivascular spaces accompanied by intracranial hypertension.

  • Liquid biopsy for detection of H3K27m and BRAF V600E mutations in patients with diffuse brainstem tumors

    by A.V. Gavryushin, L.I. Papusha, A.A. Veselkov, M.A. Zaitseva, E.A. Khukhlaeva, A.N. Konovalov, A.E. Druy

    Despite the progress in understanding the pathogenesis of diffuse brainstem tumors, treatment of these neoplasms is usually empirical and conducted without morphological and molecular verification. Liquid biopsy is a minimally invasive technique providing data on tumor biology without standard biopsy. This method is based on analysis of cell-free nucleic acids (predominantly, extracellular DNA) in biological fluids with detection of specific mutations. Despite wide implementation in diagnosis and disease monitoring in extracranial malignancies, it is infrequently applied in neuro-oncology. Objective. To estimate diagnostic value of liquid biopsy in detecting H3K27 and BRAF V600E mutations in patients with diffuse brainstem tumors. Material and methods. Lumbar puncture with cerebrospinal fluid sampling was performed in 16 patients (5 children and 11 adults) with diffuse brainstem tumors verified by neuroimaging data. Cell-free DNA (cfDNA) was used in digital droplet PCR for determination of H3F3A K28M and BRAF V600E oncogenic missense variants. In 14 patients, investigation of cfDNA was performed in parallel with analysis of correspondent mutations in DNA derived from tumor tissue. Results. None patient had BRAF V600E mutation. H3F3A K28M variant was detected in 5 CSF samples and 6 tumor specimens from patients who underwent surgical biopsy. Thus, overall sensitivity of the method in determination of H3F3A K28M variant was 92.9% (13/14). Conclusion. Liquid biopsy is highly informative for identifying the specific mutation H3F3A K28M and often verifies diffuse brainstem glioma without standard biopsy.

  • Liquid biopsy in diagnosis of central nervous system tumors

    by A.V. Gavryushin, A.A. Veselkov, E.A. Khukhlaeva, A.N. Konovalov, A.E. Druy

    Tumor tissue samples are necessary for histological diagnosis. Biopsy is associated with certain difficulties, especially in neuro-oncology. An alternative approach (liquid biopsy) is currently being developed. The last one is based on analysis of biological fluids regarding DNA of tumors and other biomarkers. This less invasive diagnostic method may be valuable to overcome the disadvantages of traditional biopsy. Objective. To analyze available literature data on potential benefits and disadvantages of liquid biopsy. Material and methods. We reviewed the PubMed database throughout the last 18 years. Results. The main targets for liquid biopsy are circulating tumor cells, extracellular vesicles, free circulating DNA and tumor microRNA. Analysis of these biomarkers is perspective for diagnostics and assessment of diseases in neuro-oncology. However, this technique is still poorly understood and has limitations. Therefore, further research is required to explore its capabilities for wider use in clinical practice. Conclusion. Tissue and liquid biopsy can improve the accuracy of diagnosis, assessment of prognosis and effectiveness of treatment of CNS tumors.

  • Recovery of consciousness under therapy with benzodiazepines. A case report and literature review

    by O.B. Belousova, A.N. Konovalov, I.A. Savin, T.M. Birg, K.N. Lapteva, D.I. Pitskhelauri, Sh.U. Kadyrov, Yu.G. Sidneva, E.A. Khhukhlaeva

    Background. Treatment of patients with prolonged and permanent disturbance of consciousness is still an extremely difficult problem. Nowadays, management is based on pathophysiological and molecular mechanisms of impaired consciousness. Several electrophysiological and pharmacological methods were proposed to restore consciousness in appropriate patients. Objective. We present recovery of clear consciousness under therapy with phenazepam and literature review devoted to therapy of these disorders. Results and conclusion. This case confirms available data on drug neuromodulation in complex treatment of patients with prolonged impairment of consciousness and substantiates the need for individual multimodal assessment of structural and functional disorders in prolonged and chronic impairment of consciousness for adequate therapy.

  • Primary tumors of the brain stem. State of the problem

    by A.V. Gavryushin, E.A. Khukhlaeva, A.A. Veselkov, I.N. Pronin, A.N. Konovalov

    Primary brainstem gliomas are still poorly studied in neurooncology. This concept includes tumors with different histological and genetic features, as well as variable clinical course and outcomes. Nevertheless, treatment implies radiotherapy without a clear idea of morphological substrate of disease in 80% of cases. Small number of studies and insufficient data on histological and genetic nature of brainstem tumors complicate clear diagnostic and treatment algorithms. This review provides current information regarding primary glial brainstem tumors. Appropriate problems and objectives are highlighted. The purpose of the review is to provide a comprehensive and updated understanding of the current state of brainstem glial tumors and to identify areas requiring further study for improvement of diagnosis and treatment of these diseases. Brainstem tumors are an understudied problem with small amount of data that complicates optimal treatment strategies. Further researches and histological verification are required to develop new methods of therapy, especially for diffuse forms of neoplasms.


  • Chordoid gliomas of the third ventricle

    by A.N. Konovalov, I.V. Chernov, M.V. Ryzhova, D.I. Pitskhelauri, Yu.V. Kushel, L.I. Astafieva, O.I. Sharipov, I.S. Klochkova, Yu.G. Sidneva, G.P. Snigireva, et al.

    Background. Chordoid glioma is a rare slow-growing tumor of the central nervous system. Available world experience includes no more than 200 cases (lesion of the third ventricle in absolute majority of cases). Recognition and treatment of chordoid glioma are currently difficult problems due to small incidence of this disease. Objective. To describe clinical manifestations and surgical treatment of chordoid glioma of the third ventricle considering literature data and own experience. Material and methods. There were 12 patients (6 men and 6 women) with chordoid glioma between 2004 and 2023 (10 patients with lesion of the third ventricle, 1 — lateral ventricle, 1 — pineal region). Only patients with tumors of the third ventricle were analyzed. Results. Total and subtotal resection was performed in 1 and 3 cases, respectively. Five patients underwent partial resection, 1 patient underwent biopsy. The follow-up data were available in 7 out of 10 patients (mean 25 months). Radiotherapy was performed in 4 patients (continued tumor growth in 2 cases). One patient died. Conclusion. Chordoid glioma is a benign tumor predominantly localized in the third ventricle. Preoperative MRI and CT in some cases make it possible to suspect chordoid glioma and differentiate this tumor from craniopharyngioma, meningioma and pituitary adenoma by such signs as isointense signal in T1WI, hyper- or isointense signal in T2WI, homogeneous contrast enhancement and edema of basal ganglia in T2 FLAIR images. The only effective treatment for chordoid glioma is surgery. Total resection is often impossible or extremely dangerous due to location of tumor, large size and invasion of the third ventricle. Postoperative mental disorders and diabetes insipidus, including severe hypernatremia, are common that requires mandatory monitoring of water and electrolyte balance.


  • Open Access

    Modern Neurosurgery — the Multidisciplinary Integration of Competences an Technologies

    by Dmitry Y. Usachev, Alexander N. Konovalov, Alexander A. Potapov, Igor N. Pronin, Nikolay A. Konovalov, Andrey V. Golanov, Gleb V. Danilov, Grigoriy L. Kobyakov, Aleksey N. Shkarubo, Кобяков Григорий Львович

    Modern neurosurgery is based on the complex integration of basic and applied neurosciences and technologies. A significant number of different diagnostic and therapeutic approaches are used to prolong a patients life and preserve its quality to the maximum. At the same time, neurosurgery is the only clinical discipline providing direct access to the living human brain. A large body of information on the nervous system state and pathology, routinely generated in neurosurgery, attract specialists from the related medical and biological sciences. Such close cooperation of physicians, biologists, chemists, physicists, mathematicians, engineers, and other specialists ensures rapid and continuous improvement of neurosurgical treatment. This article highlights the spectrum of technologies in modern neurosurgery, the research tasks facing this specialty, and briefly the activities of the National Medical Research Center for Neurosurgery named after academician N.N. Burdenko the leading neurosurgical institution of the Russian Federation in priority clinical and scientific areas.